Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Aortic Aneurysm Companies

Companies involved in the field of aortic aneurysm focus on developing medical devices, technologies, and treatments to address the diagnosis, monitoring, and intervention of aortic aneurysms. Aortic aneurysms involve the abnormal dilation or bulging of the aorta, the main blood vessel that carries blood away from the heart.

Aortic Aneurysm Key Companies Latest Aortic Aneurysm Companies Update

May 2023: Therapeutic Solutions International (TSOI) announced the launch of VasoSome Vascular Inc, a new spin-off firm focusing on addressing the "living timebomb" condition of aortic aneurysms with stem cell generated exosomes. VasoSome Vascular is presently conducting IND-enabling tests and aims to submit with the FDA by the end of 2023 to begin a Phase I/II clinical trial. The business expressed confidence, citing clinical experiences with JadiCells and other stem cell products, and stated that the field of aortic aneurysms offers several prospects for the use of regenerative medicine. the company's dedication to harnessing regenerative medicine to build new frontiers in many biological domains, with the overriding objective of enhancing patient treatments and generating shareholder value.

June 2023: Endologix LLC, a privately held global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced today that the DETOUR System has received FDA approval to treat patients with complex peripheral arterial disease (PAD). The DETOUR System's Percutaneous Transmural Arterial Bypass (PTAB) offers a revolutionary strategy to treating complicated PAD, allowing surgeons to bypass lesions in the superficial femoral artery by employing stents routed down the femoral vein to restore blood flow to the leg. This method is most beneficial for patients with large lesions (20cm-46cm in length), those who have previously failed endovascular operations, or those who may be unsuitable candidates for open surgical bypass.

List of Aortic Aneurysm Key companies in the market

AbbVie Inc. (US)

Terumo Corporation (Japan)

R. Bard Inc. (US)

Medtronic Plc. (US)

Cardiatis S.A. (Belgium)

Lombard Medical Inc (UK)

Cardinal Health Inc. (US)

Aortic Aneurysm Market Highlights:

Aortic Aneurysm Market Size

Aortic Aneurysm Market Trends

Aortic Aneurysm Market Analysis

Aortic Aneurysm Market Share

Aortic Aneurysm Market Highlights:

Aortic Aneurysm Market Trends

Aortic Aneurysm Market Analysis

Aortic Aneurysm Market Share

Aortic Aneurysm Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.